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Peste des petits ruminants virus (PPRV) causes an acute and highly contagious 
disease and belongs to the family Paramyxoviridae and genus Morbillivirus. The 
control of animal diseases is one of the primary objectives of government livestock 
departments in Pakistan. Control of any viral disease requires rapid, specific and 
sensitive diagnostic tests and efficacious vaccines. Small ruminants infected with 
PPRV are routinely diagnosed on the basis of clinical examination, gross pathology, 
histological findings and laboratory confirmation. A number of serological and 
molecular diagnostic tests are used for the detection of PPRV. Control of PPRV 
may be attained using measures including movement control of sheep and goats 
from affected areas, quarantine of infected animals, removal of potentially infected 
fomites and a restriction on the importation of sheep and goats from infected areas. 
The effective way to control PPR in Pakistan is by mass immunization of small 
ruminants as strict sanitary control measures, including the stamping out policy are 
not economically viable. Therefore, the control of PPR requires an effective vaccine 
and for this purpose several vaccines such as homologous and recombinant vaccines 
have been developed. 
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INTRODUCTION 
 
Worldwide, the livestock sector accounts for 40% of 
the agricultural gross domestic product (GDP) (Steinfeld 
et al., 2006). Within Pakistan, the livestock sector plays a 
vital role in the economy as it contributes more than 50% 
to the value addition in the agriculture sector and almost 
11% to the Pakistani GDP. In the rural community of 
Pakistan, about 30-35 million people raise livestock such 
as sheep and goats as a supplementary occupation, with 5-
6 sheep/goats per family. In Pakistan, the total population 
of sheep and goats is approximately 25.5 and 61.9 million, 
respectively. Collectively, they produce 31 million tons of 
milk, 782.1 thousand tons mutton, 45.2 thousand tons of 
wool, 21.5 thousand tons of hair and 51.2 million skins 
per year (Anonymous, 2005–2006). 
Control of animal diseases is one of the primary 
objectives of government livestock departments in 
Pakistan. Priority pathogens for intervention measures in 
Pakistan include several transboundary animal diseases 
(TADs) including rinderpest, foot and mouth disease 
(FMD), Peste des Petits Ruminants (PPR) and avian 
influenza (AI). It is estimated that PPR causes annual 
losses of more than US$ 342.15 million through high 
levels of morbidity and mortality and the resulting 
depletion of genetic stock (Hussain et al., 2008).  
PPR is an acute and highly contagious viral disease of 
mainly domestic small ruminants such as goats and sheep 
but the virus can also affect wild animals. The morbidity 
and mortality rates can be as high as 100 and 90%, 
respectively (Lefevre and Diallo, 1990), and in a severe 
outbreak, mortality can reach to 100% (Radostits et al., 
2000) although these rates can vary enormously with 
mortality sometimes being as low as 20% (Roeder and 
Obi, 1999). Due to the high mortality, PPRV was 
classified as an A-list viral pathogen by the OIE (Office 
International des Epizooties) but according to the new 
classification it is included as an OIE ‘notifiable’ disease. 
PPRV has been reported to be endemic in various parts of 
Asia and Africa (Roeder and Obi, 1999; Dhar et al., 2002; 
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Banyard et al., 2010; Sande et al., 2011). The virus can be 
genetically grouped into four distinct lineages (I, II, III, 
and IV) based on partial fusion protein (F) or 
nucleoprotein (N) gene sequence analysis. All four 
lineages have now been detected in Africa whilst only 
lineage IV appears to be circulating across Asia (Shaila et 
al., 1996; Dhar et al., 2002; Banyard et al., 2010). 
 
ETIOLOGY 
 
The etiological agent, PPRV virus belongs to the 
Order Mononegavirales, family Paramyxoviridae, genus 
Morbillivirus (Gibbs et al., 1979). Virions are 
pleomorphic in nature, varying between 130-390 nm in 
diameter. The virus envelope is 8-15 nm thick with 
glycoprotein spikes of 8.5-14.5 nm length being present 
throughout the membrane. PPRV has a non-segmented, 
single-strand negative sense RNA genome of 15,948 
nucleotides that encodes eight proteins including six 
structural proteins namely: the nucleoprotein (N), the 
phosphoprotein (P), the matrix protein (M), the fusion 
protein (F), the haemagglutinin protein (H) and the large 
polymerase protein (L), and two nonstructural proteins V 
and C; in the order 3´-N-P(C/V)-M-F-H-L-5´ (Bailey et 
al., 2005). The N protein totally encapsidates the viral 
RNA and encapsidated genomes can be observed under 
the electron microscope as ‘herringbone-like’ structures of 
approximately 14-23 nm in length (Durojaiye et al., 1985; 
Barrett  et al., 1993). These structures containing the 
genomic RNA, completely encapsidated in N protein, and 
in association with the P and L proteins, form the minimal 
replicative unit of these viruses, the ribonucleocapsid 
protein (RNP) complex. The P protein acts as a molecular 
intermediate that is proposed to bridge components of the 
RNP during both the replicase and transcriptase activities 
of the viral life cycle. Three viral proteins: M, F and H are 
associated with the viral envelope which is derived from 
the host cell membrane. The M protein is located inside 
the envelope and serves as a link between the RNP and 
the two external viral proteins, F and H, and is believed to 
be important for virus particle assembly. The virus binds 
to the host cell receptor through H during the first step of 
the infection process. Following attachment, F mediates 
the fusion of the viral envelope with the host cell 
membrane, introducing the viral RNP complex into the 
cell cytoplasm. F and in particular, H are considered to be 
very important for inducing protective host immune 
response against the virus (Barrett et al., 2005). 
The acute form of PPR is characterized by pyrexia 
(up to 41
0C), anorexia, necrosis and ulceration of mucous 
membranes, sores in the mouth, mucopurulent nasal and 
ocular discharge, necrotizing and erosive stomatitis, 
pneumonia and inflammation of gastrointestinal tract, 
leading to severe diarrhea (Lefevre and Diallo, 1990; 
Roeder and Obi, 1999). The sub-acute form of the disease 
is seen as a mild form, characterized by moderate 
hyperthermia, 39-40
0C over a 1 to 2 day period; diarrhea 
is slight and may last for 2-3 days and mucosal discharges 
are less abundant. There is no mortality in the sub-acute 
form of PPR and animals go on to convalesce (Diallo, 
2006). The main routes of PPRV transmission are via oral 
and respiratory secretions and transmission generally 
occurs following close contact between infected and 
susceptible animals (Lefevre and Diallo, 1990).  It has 
been estimated that PPRV has half life of 2.2 minutes at 
56
°C and 3.3 hours at 37
°C (Rossiter and Taylor, 1994). It 
has a long survival time in chilled and frozen tissues and 
is stable at pH 4-10 (Anonymous, 2002). 
PPRV is lymphotropic and epitheliotropic and 
produces severe lesions in organ systems rich in lymphoid 
and epithelial tissues. After entry through the respiratory 
route, PPRV multiplies in the pharyngeal and mandibular 
lymph nodes and tonsils. Two to three days post-infection 
and one to two days before the appearance of first clinical 
signs, viremia may develop, which then results in 
dissemination of the virus to the spleen, bone marrow and 
mucosa of the gastro-intestinal tract and the respiratory 
system (Scott, 1981). Acute disease is usually 
accompanied by lymphopenia and immuno-suppression, 
leading to secondary opportunistic infections (Appel and 
Summers, 1995; Murphy and Parks, 1999). 
Studies have showed that the apoptosis of infected 
cells seems to play an important role in the pathogenesis 
of PPRV in goats and sheep. In vitro infection of goat 
peripheral blood mononuclear cells with PPRV causes 
nuclear condensation and fragmentation, DNA 
fragmentation, blebbing of the plasma membrane and an 
increase in apoptotic index; supporting the fact that PPRV 
induces peripheral blood mononuclear cells to undergo 
apoptosis (Mondal et al., 2001; Guvenc
  and Gurcan, 
2009). 
PPRV is sometimes reported as being more severe in 
goats than in sheep.  However, there have been reports of 
both an increased susceptibility of sheep populations, goat 
populations and outbreaks that appear to have affected 
sheep and goat populations equally (Taylor and 
Abegunde, 1979; Roeder et al., 1994; Taylor et al., 2002; 
Singh et al., 2004; Yesilbag et al., 2005; Chauhan et al., 
2009; Wang et al., 2009). PPRV is known to infect cattle 
asymptomatically (Diallo et al., 1989; Anderson and 
McKay, 1994) and can also affect camels (Roger et al., 
2001).  
 
ADVANCES IN DIAGNOSIS 
 
Effective implementation of control measures for 
PPR require rapid, specific and sensitive methods for 
diagnosis. Small ruminants infected with PPRV are 
routinely diagnosed on the basis of clinical examination, 
gross pathology, histological findings, and laboratory 
confirmation (Diallo et al., 1995). A number of 
serological and molecular diagnostic tests are currently 
used for the detection of PPRV. 
 
Conventional Methods 
Conventional techniques such as the Agar Gel 
Immuno Diffusion (AGID) test are not routinely used for 
standard diagnosis as they lack sensitivity when compared 
to other assays (Nussieba et al., 2008; Aslam et al., 2009). 
However, Haemagglutination  tests (HA) and 
Haemagglutination Inhibition tests (HI) tests can be used 
for routine screening purposes in control programmes as 
they display comparative sensitivity alongside being 
simple to perform and cheap to produce (Manoharan et 
al., 2005).  Pak Vet J, 2011, 31(4): 267-274. 
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Virus isolation in cell culture can be attempted with 
several different cell lines where samples permit. 
Although Vero cells have been the choice for isolation 
and propagation of PPRV, it is reported that B95a, an 
adherent cell line derived from Epstein-Barr virus-
transformed marmoset B-lymphoblastoid cells, is more 
sensitive and support better growth of PPRV lineage IV as 
compared to Vero cells (Sreenivasa et al., 2006). More 
recently, Vero cells expressing the SLAM receptor have 
been used as an effective alternative for isolation in cell 
culture (Ono et al., 2001; Seki et al., 2003). The fragility 
of morbillivirus virions generally renders techniques such 
as virus isolation redundant for routine diagnostic use, 
especially where sample quality is poor. Such techniques 
are also considered to be time-consuming and 
cumbersome (Brindha et al., 2001). Virus isolation does, 
however, play an important role from a research 
perspective.  
ELISA tests using monoclonal antibodies are often 
used for serological diagnosis and antigen detection for 
diagnostic and screening purposes. For PPR antibody 
detection, the competitive ELISA is the most suitable 
choice as it is sensitive, specific, reliable, and has a high 
diagnostic specificity (99.8%) and sensitivity (90.5%) 
(Anderson and McKay, 1994; Choi et al., 2005; Khan et 
al., 2007; Khan et al., 2008; Abubakar et al., 2009). 
Immunocapture ELISA (ICE) is a rapid, sensitive and 
virus specific test for PPRV antigen detection and it can 
differentiate between RPV and PPRV (Diop et al., 2005; 
Abubakar et al., 2008) and has been reported to be more 
sensitive than the AGID test (Abraham and Berhan, 
2001). For rapid diagnosis to enable a swift implement- 
tation of control measures, further development and 
validation of pen-side tests such as the chromatographic 
strip test (Hussain et al., 2003) and the dot ELISA that can 
be performed without the need for equipments or 
technical expertise are highly desirable (Anonymous, 
2008). Conventional techniques used for PPRV detection 
are detailed in table 1. 
 
Molecular Methods 
Molecular techniques such as reverse transcription 
polymerase chain reaction (RT- PCR) (Forsyth and 
Barrett, 1995; Brindha et al., 2001; Couacy-Hymann et 
al., 2007; Farooq et al., 2008; Albayrak and Alkan, 2009) 
and nucleic acid hybridization (Shaila et al., 1989; Diallo 
et al., 1995) are generally used. These genome based 
techniques are largely used because of their high 
specificity and sensitivity. However, modern one step 
real-time RT-PCR assays specific for PPRV (Bao et al., 
2008; Kwiatek et al., 2010; Batten et al., 2011) and loop-
mediated isothermal amplification techniques (Wei et al., 
2009) are more sensitive techniques for PPRV detection 
but do not allow genetic typing of positive samples. 
RT-PCR coupled with ELISA have also been used to 
increase the analytical sensitivity of visualization of RT-
PCR products and to overcome the drawbacks of 
electrophoresis-based detection such as use of ethidium 
bromide, exposure to UV light etc (Kumar et al., 2007). 
The assay is reported to detect viral RNA in infected 
tissue culture fluid with a virus titre as low as 0.01 TCID50 
/100 µl and has been reported as being 100 and 10,000 
times more sensitive than the sandwich ELISA and RT-
PCR, respectively (Saravanan et al., 2004). 
 
CLASSICAL CONTROL MEASURES 
 
Control of PPR may be achieved using classical 
measures. These measures include restricted movement of 
sheep and goats from affected areas, quarantine of 
affected animals, elimination of contact fomites and 
restriction on the importation of sheep and goats from 
infected areas. Infected animals should be slaughtered and 
the carcasses should be burned within deep burial grounds 
(Saliki, 1998). Affected premises should be cleaned and 
disinfected with lipid solvent solutions of high or low pH, 
disinfectants (phenol, sodium hydroxide, alcohol, ether) 
and detergents (Anonymous, 2002). PPR outbreaks should 
be carefully monitored. Farmers and other livestock 
handlers need to receive education on reactionary 
procedures following disease identification and control 
measures such as movement restriction of animals with 
clinical signs, basic hygienic practices, and biosecurity 
levels within and between flocks. This is important to 
limit the spread and severity of PPR outbreaks 
(Balamurugan  et al., 2010). Control of PPR outbreaks 
may also rely on movement control (quarantine) 
combined with the use of focused (“ring”) vaccination and 
prophylactic immunization in high-risk populations. 
 
Vaccines 
The most effective way to control PPR is mass 
immunization of small ruminants as often, farmers in 
areas where the virus is endemic are unable to afford and 
implement the strict sanitary control measures, including 
the stamping out policy, required to contain the virus. 
Therefore the control of PPR requires an effective vaccine 
and for this purpose several vaccines including both 
homologous and recombinant vaccines have been 
developed. 
 
Conventional vaccines 
Early attempts to control PPR involved the use of the 
live attenuated tissue culture RPV vaccine (TCRV) and 
adequate protection was afforded to small ruminants using 
this vaccination policy (Plowright and Ferris, 1962). Sera 
from vaccinated animals showed the presence of 
neutralising antibodies against RPV but not against PPRV 
and after PPRV challenge, the neutralizing antibody 
response to PPRV increased and all animals were 
protected (Taylor, 1979). However, the RPV eradication 
campaign required a halt in the use of the TCRV as 
serological testing was not able to differentiate between 
naturally infected and vaccinated animals. This meant that 
vaccine derived RPV serological positivity complicated 
serosurveillance initiatives set up to try and detect the 
presence of naturally circulating forms of rinderpest of 
low pathogenicity. A homologous PPRV vaccine was 
introduced after the successful attenuation of the Nigeria 
75/1 strain through serial passage on Vero cells (Diallo et 
al., 1989). A similar vaccine was produced in Pakistan 
using the PPRV Nigeria 75/I (PPR 75-1 LK 6 Vero 75) 
from France and it was found that it could be safely used 
for immunization of small ruminants against PPR (Asim 
et al., 2009).  In India, several vaccines have been Pak Vet J, 2011, 31(4): 267-274. 
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Table 1: Detail of conventional methods for the detection and confirmation of PPR  
Sr 
# Test  Name  Acronym Application 
(Lab or Field) 
Feature Detected 
(Antigen or 
Antibody) 
Reference 
1.  Agar gel immuno-diffusion   AGID  Both  Both  Obi and Patrick (1984) 
2.  Counter Immuno-
electrophoresis  
CIEP Both  Both  Atta-ur-Rahman  et al. (2004) 
3.  Dot enzyme immunoassay  --  Lab  Antigen  Obi and Ojeh (1989) 
Saravanan et al. (2006) 
4.  Differential immuno-histo-
chemical staining of tissue 
sections  
IH staining  Lab  Antigen  Saliki et al. (1994) 
5.  Haemagglutination and 
Haemagglutination inhibition 
tests  
HA and HI  Both  Both  Raj et al. (2000) 
Ezeibe et al. (2008) 
Manoharan et al. (2005) 
6.  Immuno-filtration   IF  Lab  Antigen  Raj et al. (2008) 
7.  Latex agglutination tests   LA  Field  Antigen  Keerti et al. (2009) 
8.  Virus isolation   VI  Lab  Antigen  Brindha et al. (2001) 
9.  Competitive enzyme-linked 
immunosorbent assay (c-ELISA),  
cELISA Lab  Antibody  Anderson  et al. (1991) 
Anderson and McKay (1994) 
10.  Novel sandwich ELISA   sELISA  Lab  Antigen  Saravanan et al. (2008) 
11.  Immuno-capture enzyme-linked 
immunosorbent assay  
Ic-ELISA Lab  Antigen  Libeau  et al. (1994) 
Singh et al. (2004) 
Diop et al. (2005) 
Abubakar et al. (2008) 
 
developed including the live attenuated PPRV Sungri/96 
vaccine strain that has been standardized for use (Hegde et 
al., 2008).  
 
Thermostable vaccines 
As PPRV is thermolabile, it is necessary to maintain a 
cold chain to preserve vaccine potency. The thermo-
stability of the TCRV vaccine was improved through the 
application of freeze drying technology (Mariner et al., 
1990). Similarly, Worrwall et al. (2001) developed a 
thermo-tolerant vaccine freeze dried in the presence of a 
cryo-protectant containing trehalose. This vaccine is 
stable at 45°C for 14 days with minimal loss of potency. 
Two thermostable vaccines were developed and their 
thermo-stability when checked at both 37°C and 40°C, 
demonstrated a shelf life of 7.62 and 3.68 days, 
respectively   (Sen et al., 2010).  Heavy water has been  
reported to enhance the thermo-stability of PPRV 
vaccines. When compared to conventional virus, 
deuterated virus reconstituted in heavy water-based 
diluents resulted in the maintenance of higher titers (Sen 
et al., 2009).  
 
Recombinant vaccines 
Following the successful eradication of RPV, 
attention has now been focused on the potential to 
eradicate PPRV. Currently, a live attenuated vaccine is 
available, however, as seen with the RPV eradication 
campaign, application of the current vaccines and 
companion serological diagnostic ELISA test does not 
allow serological differentiation of naturally infected from 
vaccinated animals, the so called ‘DIVA’ concept. The 
development of recombinant vaccines that fulfill DIVA 
requirements is very important for the eradication of the 
disease from the country.  
Historically, the F and H proteins of several 
morbilliviruses have been expressed in heterologous live 
virus vector systems which have proven to be effective as 
vaccines (Romero et al., 1994; Stephensen et al., 1997). 
One such recombinant dual vaccine was developed using 
attenuated capripoxvirus strain KS-1 that expressed the 
PPRV F protein which proved to be effective at a low 
dose (0.1 PFU) (Berhe et al., 2003). Similarly two 
recombinant capripoxviruses, expressing PPRV 
glycoprotein H or F, were constructed. These DIVA 
vaccines proved to induce long-lasting immunity against 
PPRV (Chen et al., 2010). Other studies used attenuated 
modified vaccinia virus Ankara strain (MVA) as a vector 
for PPRV immunogens. Two recombinant viruses were 
constructed namely MVA-F and MVA-H expressing the 
full length PPRV F and H glycoproteins, respectively. 
Goats vaccinated with these vaccines were completely 
protected from the disease which gave an indication that 
mass vaccination with both or one of the two recombinant 
virus vaccines could help in PPRV eradication (Chandran 
et al., 2010). One caution when considering use of such 
pox-vectored vaccines is the possibility of preexisting 
immunological responses to naturally circulating 
poxviruses that may interfere with this vaccination 
strategy. Furthermore, when relying solely on the PPRV 
competitive ELISA, use of these vectored vaccines does 
not enable DIVA.  
To reduce the cost of vaccination, bi or trivalent 
vaccines should be developed that can provide protection 
against PPRV as well as other important diseases of sheep 
and goats. This would enhance poverty alleviation in areas 
where multiple viral pathogens of small ruminants exist 
(Diallo, 2006; Banyard et al., 2010; Abubakar et al., 
2011). 
 
Edible Vaccines 
Recent work has provided data to support the 
prospect of generating vaccines in plants and has shown 
that transgenic plants can synthesize and assemble 
immunogenic proteins. Furthermore, oral immunization 
with transgenic plants expressing vaccine antigens has 
been shown to produce specific immune responses 
(Mason  et al., 1992). Transgenic plants could be an Pak Vet J, 2011, 31(4): 267-274. 
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effective way of vaccination against viral diseases 
endemic across the developing world as production costs 
are greatly reduced when compared to vaccines produced 
using expensive cell culture-based expression system. 
Compared with parenteral antigen delivery, oral vaccine 
delivery is a more convenient way of immunization and 
by the induction of mucosal immunity, offers more 
effective protection against pathogens interacting with 
host mucosal surfaces (Prasad et al., 2004; Streatfield 
2005). 
Expression of the H gene of PPRV in pigeonpea 
(Cajanus cajan (L.) Millsp.) for the development of an 
edible vaccine against PPR has been reported (Prasad et 
al., 2004). A 2 kb fragment containing the coding region 
of the H gene from an Indian PPRV isolate was cloned 
into the binary vector pBI121 and mobilized into 
Agrobacterium tumefaciens strain GV3 101. However, the 
immunogenicity and extent of protection offered by oral 
delivery of the H protein expressed in pigeonpea remains 
to be tested. The production of vaccine antigens in plants 
in their immunogenic forms creates the possibility of 
economically favourable “bio-farming” for the 
development of PPRV vaccine. 
Whilst the generation and ingestion of transgenic 
plants could be an attractive mechanism of immunization, 
one drawback is the potential inclusion of pesticide 
residues as possible contaminants within plants. This may 
increase production costs through the necessity to remove 
these substances during the purification process (Floss et 
al., 2007). 
 
ANTIVIRAL THERAPY 
 
Whilst extensive research
 into vaccination strategies 
to protect small ruminants against PPRV is ongoing, 
ultimately vaccines can only serve as preventive tools to
 
induce protective immune responses prior to infection.
 
Research into antiviral therapies may develop effective 
therapeutics that could help
 virus control when animals 
are newly infected
 or are at high risk of exposure to virus 
within the herd. However, questions related to the use of 
antiviral compounds such as efficacy, selectivity, safety, 
route of administration, uptake and clearance of the 
compound in the animal, development of drug-resistant 
mutants, possible risk to humans of residual compound in 
food producing animals, etc. need to be addressed and 
further in vivo research will be required for this purpose 
(De Almeida et al., 2007; Goris et al., 2008). 
To control PPRV following the onset of clinical 
disease, one antiviral strategy that could be pursued is the 
silencing of gene expression using RNA interference 
(RNAi). In vitro inhibition of PPRV and RPV replication 
by using synthetic short interfering RNAs
 (siRNAs) has 
been demonstrated (De Almeida et al., 2007). siRNAs 
targeting
 the N gene of PPRV and RPV resulted in a >80 
% reduction in virus replication in vitro. siRNAs
 NPPRV6 
and NPPRV7, targeting two conserved regions of PPRV, 
showed clear inhibition of PPRV replication, reported as a
 
marked decrease in cytopathic effect, detection of virus 
antigen by immunofluorescence staining,
 decreased viral 
titres and decreased quantities of viral RNA being 
detected. In vivo therapy of RNAi requires the efficient
 
delivery of siRNA molecules to the appropriate tissues. 
Both plasmids and viral vectors expressing short hairpin 
RNA sequences
 specific for virus genes may be used for 
this purpose. Another antiviral therapy was investigated 
by Sujatha et al. (2009) who reported the in vitro antiviral 
activity of 4, 4′-(arylmethylene)bis(3-methyl-1-phenyl-
pyrazol-5-ols) against PPRV. The synthesized compounds 
showed excellent antiviral activity against PPRV and were 
found to be more potent than the standard drug ribavirin 
used.  
 
Conclusions 
The ongoing scientific research into the detection of, 
protection against and molecular characteristics exhibited 
by PPRV and related morbilliviruses across the globe will 
hopefully lead to the development of further safe and 
effective mechanisms by which to control these viruses. 
PPRV continues to constitute a huge economic burden on 
the agricultural sustainability both within Pakistan and 
across the developing world. The lessons learnt from the 
success of the RPV eradication campaign must now be 
translated to PPRV. The development of novel vaccines 
and companion diagnostic assays that enable DIVA 
requirements to be met may make a PPRV eradication 
campaign economically viable. With the appropriate tools 
in place, attempts to globally eradicate PPRV in the same 
way as has been achieved for RPV may be a realistic goal.  
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